P1523: IMMUNOGENICITY OF THE 13-VALENT PNEUMOCOCCAL CONJUGATED VACCINE FOLLOWED BY THE 23-VALENT POLYSACCHARIDE VACCINE IN CHRONIC LYMPHOCYTIC LEUKEMIA

• Sabine Haggenburg,
• Hannah Garcia Garrido,
• Iris Kant,
• Hanneke van der Straaten,
• Fransien De Boer,
• Sabina Kersting,
• Djamila Issa,
• Doreen Te Raa,
• Hein Visser,
• Arnon Kater,
• Abraham Goorhuis,
• Koen De Heer

Affiliations

Sabine Haggenburg

1 Amsterdam UMC, location University of Amsterdam, Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands

Hannah Garcia Garrido

3 Amsterdam UMC, locatie AMC, Infectious Diseases, Center for Tropical Medicine and Travel Medicine, Amsterdam, The Netherlands

Iris Kant

1 Amsterdam UMC, location University of Amsterdam, Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands

Hanneke van der Straaten

4 Hospital St Jansdal, Internal Medicine, Harderwijk, The Netherlands

Fransien De Boer

5 Ikazia Hospital Rotterdam, Internal Medicine, Rotterdam, The Netherlands

Sabina Kersting

6 Haga Hospital, Hematology, Den Haag, The Netherlands

Djamila Issa

7 Jeroen Bosch Ziekenhuis, Internal Medicine, ‘s-Hertogenbosch, The Netherlands

Doreen Te Raa

8 Gelderland Valley Hospital, Internal Medicine, Ede, The Netherlands

Hein Visser

9 Noordwest Ziekenhuisgroep locatie Alkmaar, Internal Medicine, Alkmaar, The Netherlands

Arnon Kater

10 Amsterdam UMC, locatie AMC, Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands

Abraham Goorhuis

11 Amsterdam UMC, locatie AMC, Infectious Diseases, Center for Tropical medicine and Travel Medicine, Amsterdam, The Netherlands

Koen De Heer

10 Amsterdam UMC, locatie AMC, Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands